8-K: Horizon Finance Reports Strong Q3 2025, Advances Merger

Horizon Technology Finance Corporation announced solid third-quarter 2025 financial results, including increased net investment income and a higher portfolio yield, while progressing its merger with Monroe Capital Corporation.

Summary

• Net investment income (NII) for Q3 2025 was $14.0 million, or $0.32 per basic share, compared to $11.8 million, or $0.32 per basic share, for Q3 2024.
• Net asset value (NAV) was $315.7 million, or $7.12 per share, as of September 30, 2025, a decrease from $9.06 per share as of September 30, 2024.
• The annualized portfolio yield on debt investments increased to 18.6% for the quarter, up from 15.9% in the prior-year period.
• The company ended the quarter with a committed backlog of $119 million.
• Distributions totaling $0.33 per share have been declared for January, February, and March 2026.
• Horizon is moving forward with its merger with Monroe Capital Corporation (MRCC), subject to shareholder approvals and other closing conditions.
• The company funded three new loans totaling $15.0 million and acquired remaining assets of a co-lender for $22.5 million, which had a fair value of $36.5 million.
• Raised approximately $10.6 million in net proceeds through its at-the-market (ATM) offering program.
• Experienced liquidity events from eight portfolio companies, including warrant exercises and loan prepayments.
• The weighted average credit rating of the loan portfolio improved to 2.9 as of September 30, 2025, from 3.0 at June 30, 2025, and 3.1 at December 31, 2024.

Sentiment

Score: 7

Explanation: The company reported strong operational results with increased NII, higher portfolio yield, and improved credit quality. Strategic initiatives like the MRCC merger and co-lender acquisition are positive. However, a notable decrease in NAV per share and the potential for lower future distributions introduce some caution, preventing a higher score.

Positives

• Net investment income increased to $14.0 million in Q3 2025 from $11.8 million in Q3 2024.
• Annualized portfolio yield on debt investments rose significantly to 18.6% in Q3 2025 from 15.9% in Q3 2024.
• Net unrealized appreciation on investments was $40.5 million ($0.94 per basic share) in Q3 2025, up from $29.3 million ($0.80 per basic share) in Q3 2024.
• Net increase in net assets resulting from operations was $30.7 million ($0.71 per basic share) in Q3 2025, a substantial increase from $7.3 million ($0.20 per basic share) in Q3 2024.
• Net realized loss on investments decreased to $22.5 million in Q3 2025 from $33.9 million in Q3 2024.
• Total expenses decreased to $12.0 million in Q3 2025 from $12.4 million in Q3 2024, primarily due to a lower base management fee.
• The weighted average credit rating of the loan portfolio improved to 2.9, indicating better asset quality.
• Successfully acquired the remaining assets of a co-lender for $22.5 million, which had a fair value of $36.5 million, being accretive to net asset value per share.
• Strengthened the balance sheet by completing a $40 million convertible notes offering and raising capital through the ATM program.
• Achieved positive outcomes with respect to two stressed investments, demonstrating effective risk management.
• The merger with Monroe Capital Corporation is progressing, expected to enhance competitive positioning for larger venture lending transactions.

Negatives

• Net asset value per share decreased to $7.12 as of September 30, 2025, from $9.06 as of September 30, 2024.
• The Board indicated that future distributions, to be determined in February 2026, could be lower than the current $0.11 per share level, considering the impact of the anticipated merger.
• Despite an overall improvement in credit rating, the fair value of debt investments with an internal credit rating of 1 (highest risk) increased to $29.3 million from $26.9 million in the prior quarter, even as the number of such investments decreased from five to four.

Risks

• Forward-looking statements are not guarantees of future performance and involve a number of risks and uncertainties, with actual results potentially differing materially.
• There is no assurance that any additional lenders will make commitments under the Key Facility, which allows for an increase in total loan commitment up to $300.0 million.
• The Board's determination of future distribution amounts in February 2026 could result in a declaration of distributions lower than the current level, taking into account the anticipated merger with Monroe Capital Corporation.

Future Outlook

The company remains excited to complete its merger with Monroe Capital Corporation (MRCC), which, along with its active relationship with Monroe Capital, is expected to better position it to win larger venture lending transactions and grow its portfolio. The Board will determine the next amount of distributions in February 2026, considering Q4 2025 operating results, spillover income, and the anticipated impact of the MRCC merger, which could potentially result in a declaration of distributions lower than the current level.

Management Comments

• "We produced a solid third quarter by increasing our net asset value and achieving strong NII, as we moved toward completing our merger with MRCC."
• "In the quarter, we originated a modest number of new loans and acquired the portfolio of a co-lender, which was accretive to our net asset value per share."
• "We also achieved positive outcomes with respect to two stressed investments, which is a testament to our ability to work with our portfolio companies to achieve positive solutions in downside situations."
• "We also strengthened our balance sheet in the quarter, completing a $40 million convertible notes offering and accretively raising capital through our ATM program."
• "Moving forward, we remain excited to complete the merger with MRCC, which along with our active relationship with Monroe Capital will better position us to win larger venture lending transactions and grow our portfolio."

Industry Context

Horizon Technology Finance operates in the specialized and competitive venture debt and specialty finance sector, providing crucial capital to technology, life science, healthcare information and services, and sustainability industries. The ongoing merger with Monroe Capital Corporation and the active relationship with Monroe Capital indicate a strategic move to enhance market presence and capacity for larger transactions, reflecting a trend towards consolidation and scale in the venture lending space to better serve growing companies and compete effectively.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to benchmark against industry standards. The analysis is based solely on the company's internal performance metrics and strategic initiatives.

Stakeholder Impact

• Shareholders: Benefit from declared distributions and potential synergies from the MRCC merger, but face dilution from ATM offerings and convertible note conversions, and a decrease in NAV per share.
• Portfolio Companies: Benefit from continued funding and the company's ability to work through stressed investments, as well as potential for larger venture lending transactions post-merger.
• Creditors: The company's leverage ratio remains below target, and asset coverage is strong, indicating a healthy financial position for debt holders.

Next Steps

• Host a conference call on October 29, 2025, to discuss financial results.
• The Board will determine the next amount of distributions in February 2026, considering Q4 2025 results, spillover income, and the impact of the anticipated merger with Monroe Capital Corporation.
• Completion of the merger with Monroe Capital Corporation, subject to shareholder approvals and other closing conditions.

Key Dates

Recommendation

The company demonstrates strong operational performance with increased net investment income and a higher portfolio yield, alongside strategic progress on the Monroe Capital Corporation merger. However, the significant decline in net asset value per share and the explicit warning about potentially lower future distributions warrant a cautious approach. While the underlying business appears robust and management is actively pursuing growth, these factors suggest a 'hold' recommendation until the full impact of the merger and future distribution policy becomes clearer, allowing investors to assess the long-term value proposition more accurately.

Keywords

Venture debt, Specialty finance, Technology finance, Life science, Healthcare information, Sustainability, Secured loans, Business development company, BDC, Monroe Capital, HRZN, MRCC, Q3 2025 earnings, Financial results